Viewing Study NCT00672256


Ignite Creation Date: 2025-12-24 @ 11:16 PM
Ignite Modification Date: 2026-01-02 @ 10:32 PM
Study NCT ID: NCT00672256
Status: COMPLETED
Last Update Posted: 2014-07-23
First Post: 2008-05-04
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Neuroimaging Decision Making and Response Inhibition During Smoking Abstinence
Sponsor: Duke University
Organization:

Study Overview

Official Title: Neuroimaging Decision Making and Response Inhibition During Smoking Abstinence
Status: COMPLETED
Status Verified Date: 2013-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: SmokeAtt02
Brief Summary: The broad objective of this proposal is to identify functional neuroanatomical correlates of impairments in response inhibition during smoking abstinence. We will measure changes in performance and regional blood oxygenation levels using functional magnetic resonance imaging (fMRI)while smokers complete tasks designed to assess decision making and response inhibition.

Our primary hypothesis is that smoking abstinence will result in impaired response inhibition accompanied by decreases in blood-oxygenation-level-dependent (BOLD) fMRI signal in brain regions associated with these cognitive processes including frontal cortex and the ventral striatum. Abstinence may also result in performance-related increases in activation in brain regions associated with effortful processing including the anterior cingulate cortex in effort to compensate for deficits in other regions.
Detailed Description: Participants will learn and practice a Go/No-Go reaction time task (Garavan, Hester, Murphy, Fassbender, \& Kelly, 2006) that measures inhibitory and excitatory aspects of behavioral control. During the task subjects are presented with an alternating series of Xs and Ys in the center of the screen and must press a button every time they see a Go trial (the letter 'Y' or the letter 'X') while inhibiting a response when they are presented with a No-Go trial (any interruption of the X Y alternating stream, e.g., X Y Y).

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
DA017261 None None View
9270 OTHER Duke legacy protocol number View